{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:55:41Z","timestamp":1792248941687,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T00:00:00Z","timestamp":1498003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust UK","doi-asserted-by":"publisher","award":["085860"],"award-info":[{"award-number":["085860"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000317","name":"Action Medical Research","doi-asserted-by":"publisher","award":["SP4252"],"award-info":[{"award-number":["SP4252"]}],"id":[{"id":"10.13039\/501100000317","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Myositis Support Group UK"},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"crossref","award":["14518"],"award-info":[{"award-number":["14518"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"crossref","award":["20164"],"award-info":[{"award-number":["20164"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000852","name":"Henry Smith Charity","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000852","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Great Ormond Street Children's Charity","award":["V1268"],"award-info":[{"award-number":["V1268"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Biomedical Research Centre"},{"name":"Institute of Child Health University College London"},{"name":"UK Juvenile Systemic Lupus Erythematosus"},{"name":"BMA Doris Hillier"},{"name":"Bath Institute of Rheumatic Diseases"},{"name":"NIHR Biomedical Research Centre"},{"DOI":"10.13039\/100000001","name":"NHS Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dubowitz Neuromuscular Centre","award":["512315"],"award-info":[{"award-number":["512315"]}]},{"name":"Neuromuscular Centres in London"},{"name":"NIHR Manchester Musculoskeletal Biomedical Research"},{"name":"Arthritis Research UK Centre","award":["20385"],"award-info":[{"award-number":["20385"]}]},{"DOI":"10.13039\/100005544","name":"CAPS","doi-asserted-by":"publisher","award":["20542"],"award-info":[{"award-number":["20542"]}],"id":[{"id":"10.13039\/100005544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018817","name":"LUPUS UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018817","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"crossref","award":["ARUK-20621"],"award-info":[{"award-number":["ARUK-20621"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000836","name":"University of Liverpool","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jaut.2017.06.007","type":"journal-article","created":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T22:16:32Z","timestamp":1498515392000},"page":"55-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"special_numbering":"C","title":["Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort"],"prefix":"10.1016","volume":"84","author":[{"given":"Sarah L.","family":"Tansley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Simou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Shaddick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe E.","family":"Betteridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha","family":"Gunawardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Midgley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy R.","family":"Wedderburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaut.2017.06.007_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/rheumatology\/keq261","volume":"50","author":"Martin","year":"2011","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.jaut.2017.06.007_bib2","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/rheumatology\/keu259","article-title":"Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset","volume":"53","author":"Tansley","year":"2014","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jaut.2017.06.007_bib3","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/ar4600","article-title":"Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study","volume":"16","author":"Tansley","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.jaut.2017.06.007_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.jaut.2017.06.007_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.jaut.2017.06.007_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","article-title":"Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression","volume":"48","author":"Gunawardena","year":"2009","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jaut.2017.06.007_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MD.0b013e31816bc604","article-title":"Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity","volume":"87","author":"Bingham","year":"2008","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.jaut.2017.06.007_bib8","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.39753","article-title":"Muscle biopsy in combination with myositis-specific autoantibodies aids prediction of outcomes in juvenile dermatomyositis","volume":"68","author":"Deakin","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.jaut.2017.06.007_bib9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/acr.22212","article-title":"Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies","volume":"66","author":"Huber","year":"2014","journal-title":"Arthritis Care Res."},{"issue":"6","key":"10.1016\/j.jaut.2017.06.007_bib10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(83)80706-9","article-title":"Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification","volume":"103","author":"Bowyer","year":"1983","journal-title":"J.\u00a0Pediatr."},{"issue":"11","key":"10.1016\/j.jaut.2017.06.007_bib11","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","author":"Ramanan","year":"2005","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.jaut.2017.06.007_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.122196","article-title":"Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis","volume":"47","author":"Fisler","year":"2002","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.jaut.2017.06.007_bib13","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1212\/NXI.0000000000000172","article-title":"Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease","volume":"2","author":"Mammen","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.jaut.2017.06.007_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N.\u00a0Eng. J. M."},{"issue":"10","key":"10.1016\/j.jaut.2017.06.007_bib15","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1002\/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO;2-8","volume":"42","author":"Lovell","year":"1999","journal-title":"Arthritis Rheumatol."},{"issue":"10019","key":"10.1016\/j.jaut.2017.06.007_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","article-title":"Prednisone versus prednisone plus cyclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial","volume":"387","author":"Ruperto","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jaut.2017.06.007_bib17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/rheumatology\/ken085","article-title":"Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study","volume":"47","author":"Adib","year":"2008","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.jaut.2017.06.007_bib18","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/art.34410","article-title":"Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort","volume":"64","author":"Watson","year":"2012","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.jaut.2017.06.007_bib19","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.jaut.2017.06.007_bib20","first-page":"1320","article-title":"Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease","volume":"17","author":"McHugh","year":"1990","journal-title":"J.\u00a0Rheumatol."},{"issue":"11","key":"10.1016\/j.jaut.2017.06.007_bib21","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/rheumatology\/kev229","article-title":"Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience","volume":"54","author":"Klein","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2017.06.007_bib22","series-title":"R: a Language and Environment for Statistical Computing","author":"Team","year":"2012"},{"issue":"i12","key":"10.1016\/j.jaut.2017.06.007_bib23","article-title":"Glmulti: an R package for easy automated model selection with (generalized) linear models","volume":"34","author":"Calcagno","year":"2010","journal-title":"J.\u00a0Stat. Softw."},{"issue":"5","key":"10.1016\/j.jaut.2017.06.007_bib24","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.20179","article-title":"Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies","volume":"50","author":"Huber","year":"2004","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.jaut.2017.06.007_bib25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","article-title":"Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis","volume":"68","author":"Betteridge","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"14","key":"10.1016\/j.jaut.2017.06.007_bib26","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1177\/0961203316644333","article-title":"Differences in disease phenotype and severity in SLE across age groups","volume":"25","author":"Ambrose","year":"2016","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.jaut.2017.06.007_bib27","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/rheumatology\/kem265","article-title":"HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap","volume":"46","author":"Wedderburn","year":"2007","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.jaut.2017.06.007_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/BOR.0000000000000224","article-title":"Comparing and contrasting clinical and serological features of juvenile and adult-onset myositis: implications for pathogenesis and outcomes","volume":"27","author":"Tansley","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2017.06.007_bib29","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.160871","article-title":"Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients","author":"Tansley","year":"2017","journal-title":"J.\u00a0Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2017.06.007_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acr.22920","article-title":"Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle","volume":"69","author":"Pinal-Fernandez","year":"2017","journal-title":"Arthritis Care Res."},{"issue":"12","key":"10.1016\/j.jaut.2017.06.007_bib31","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s10067-015-3059-y","article-title":"The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review","volume":"34","author":"Vermaak","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2017.06.007_bib32","first-page":"CD003643","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","volume":"8","author":"Gordon","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.jaut.2017.06.007_bib33","first-page":"593","article-title":"One year in review 2015: idiopathic inflammatory myopathies","volume":"33","author":"Barsotti","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2017.06.007_bib34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12891-015-0710-3","article-title":"Biologic predictors of clinical improvement in rituximab-treated refractory myositis","volume":"16","author":"Reed","year":"2015","journal-title":"BMC Musculoskeletdisord."},{"issue":"3","key":"10.1016\/j.jaut.2017.06.007_bib35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.38270","article-title":"Predictors of clinical improvement in rituximab-treated refractory adult and juvenile Dermatomyositis and adult polymyositis","volume":"66","author":"Aggarwal","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.jaut.2017.06.007_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pathol.2016.03.012","article-title":"Diagnostic performance of a commercial immunoblot assay for myositis antibody testing","volume":"48","author":"Bundell","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.jaut.2017.06.007_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","article-title":"Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera","volume":"433","author":"Cavazzana","year":"2016","journal-title":"J.\u00a0Immunol. Methods"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117301701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117301701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:16:15Z","timestamp":1760256975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841117301701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":37,"alternative-id":["S0896841117301701"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2017.06.007","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2017.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}